IP Library Granted Patent US 8,372,965
Granted Patent B2
US 8,372,965 · App. 12/461,144 · Granted Feb 12, 2013

Nucleotide sequences for the detection of enterohaemorrhagic

Inventors: Dominique Therese Marie Frechon (Paris, FR); Françoise Claudine Louré (Paris, FR); Dominique Thierry (Boulogne, FR)
Assignee: Bio-Rad Innovations
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,965
App. No.
12/461,144
Granted
Feb 12, 2013
Kind
B2
Abstract

Nucleic sequences of plasmid origin are isolated from bacteria of the enterohaemorrhagic Escherichia coli group (EHEC) and used for the identification of EHEC(s), especially those possessing the genes encoding the virulence factors enterohaemolysin and intimin, and more particularly the specific detection of serotype O157:H7, and in detection kits.

Claims (52)

1. A pair of isolated nucleic acids selected from the group consisting of:

SEQ ID NO: 3 and SEQ ID NO: 4,

SEQ ID NO: 5 and SEQ ID NO: 6,

SEQ ID NO: 6 and SEQ ID NO: 7,

SEQ ID NO: 6 and SEQ ID NO: 8,

SEQ ID NO: 6 and SEQ ID NO: 9,

SEQ ID NO: 21 and SEQ ID NO: 22, and

SEQ ID NO: 23 and SEQ ID NO: 24.

2. A kit for detecting EHECs, comprising:

at least two oligonucleotides primers selected from the group consisting of:

SEQ ID NO: 21:

5′-CCACCTGAACGATAAGCGGAAC-3′

SEQ ID NO: 22:

5′-CACCTTCCTTCCATCCTCAGAC-3′

SEQ ID NO: 23:

5′-ATCCCAGCGCGCTCCAGCTG-3′

SEQ ID NO: 24:

5′-ACCCATGATGGCGCATCTGATG-3′

SEQ ID NO: 25:

5′-ACGTTCTGGTCTTACGGGTGATGTAGGTTTT-

3′

SEQ ID NO: 26:

5′-TAGTGAAGCGGTGACAGCATATCAGACGGCT-

3′

SEQ ID NO: 27

5′-GTGAGATAGGCACAACAATGA-3′

optionally at least one oligonucleotide probe selected from the group consisting of:

SEQ ID NO: 21:

5′-CCACCTGAACGATAAGCGGAAC-3′

SEQ ID NO: 22:

5′-CACCTTCCTTCCATCCTCAGAC-3′

SEQ ID NO: 23:

5′-ATCCCAGCGCGCTCCAGCTG-3′

SEQ ID NO: 24:

5′-ACCCATGATGGCGCATCTGATG-3′

SEQ ID NO: 25:

5′-ACGTTCTGGTCTTACGGGTGATGTAGGTTTT-

3′

SEQ ID NO: 26:

5′-TAGTGAAGCGGTGACAGCATATCAGACGGCT-

3′

SEQ ID NO: 27:

5′-GTGAGATAGGCACAACAATGA-3′.

3. The kit according to claim 2 , comprising:

two oligonucleotides of sequences SEQ ID NO: 21 and SEQ ID NO: 22, as a pair of primers, and

two oligonucleotides of sequences SEQ ID NO: 25 and SEQ ID NO: 27, for detection.

4. A kit for detecting E. coli 0157:H7, comprising:

at least two oligonucleotide primers selected from the group consisting of sequences SEQ ID NO: 3-SEQ ID NO: 20; and, optionally,

at least one oligonucleotide probe selected from the group consisting of sequences SEQ ID NO: 3-SEQ ID NO: 20.

5. The kit according to claim 4 , comprising:

two oligonucleotides of sequences SEQ ID NO: 5 and SEQ ID NO: 6, as a pair of primers,

two oligonucleotide of sequences SEQ ID NO: 15 and SEQ ID NO: 18, for detection.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2019
From: BIO-RAD INNOVATIONS
To: BIO-RAD EUROPE GMBH
Reel/Frame 049122/0754 →
CHANGE OF NAME Recorded Aug 30, 2012
From: BIO-RAD PASTEUR
To: BIO-RAD INNOVATIONS
Reel/Frame 028885/0071 →
Priority Claims (1)
FR 98 05329 · Apr 28, 1998 · national
Continuity (2)
Division 09674277
Related Publication 20100081138A1 · Apr 1, 2010